Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis

Kantarjian, Hagop M., Hughes, Timothy P., Larson, Richard A. · Leukemia · 2021